Nektarios Tavernarakis, Research Director at the Institute of Molecular Biology and Biotechnology (IMBB) of the Foundation of Research and Technology Hellas (FORTH), and Professor at the Medical School of the University of Crete was elected a Corresponding Member of the Academy of Athens.

Scientists at the Institute of Electronic Structure and Laser (IESL) of the Foundation for Research and Technology- Hellas (FORTH) led by Dr. Wolf von Klitzing created an accelerator ring for neutral atoms that is able to accelerate Bose-Einstein condensates to speeds much faster than the speed of sound and transport them to record distances.

The most important Polymer Scientists from Academic and Research Institutions from all over the world will be gathering at the Creta Maris Convention Center & Beach Resort in Hersonissos from Sunday the 9th to Friday the 14th of June 2019.

Graphene, as one-atom-thick membrane, is susceptible to morphological instabilities such as wrinkles, crumples and folds, which are attributed to several physical causes, such as the mismatch between its thermal expansion and its host substrate or the relaxation of a pre-strained substrate. A particular pattern encountered in graphene grown via Chemical Vapour Deposition is that of mosaic formation, which results from the imposition of thermo-mechanical stresses upon cooling from high temperatures.

The findings of the study, published today in the premier international scientific journal Nature Neuroscience, reveal a novel molecular mechanism underlying the beneficial effects of mitophagy, the cellular process of mitochondria recycling, against the pathogenesis of Alzheimer’s disease. IMBB Researchers, Dr. Konstantinos Palikaras and Dr. Nektarios Tavernarakis (Professor at the Medical School, University of Crete, and Chairman of the Board at FORTH) in collaboration with the team of Prof. Vilhem Bohr at the National Institute on Aging (NIA) of the National Institutes of Health, (NIH) in Baltimore, USA, together with Dr. Evandro Fang at the University of Oslo and the Akershus University Hospital, Lørenskog, Norway, demonstrated that mitophagy is impaired inAlzheimer’s disease and that its pharmacological stimulation reverses the disease’s pathological features, including cognitive deficits.